Table 2 Access to health care services among transgender women and transfeminine people in China, December 2019–June 2020 (N = 277)
Health care services | N (%) |
|---|---|
Hormone intervention history | Â |
 Have or currently undergoing | 118 (42.6) |
 Never | 159 (57.4) |
Gender affirming surgery | Â |
 Have or currently undergoing | 26 (9.4) |
 Never | 251 (90.6) |
HIV testing | Â |
 No | 57 (20.6) |
 Yes |  |
  Lifetime HIV testing | 220 (79.4) |
  Lifetime facility-based HIV testing | 190 (86.4) |
  Lifetime HIV self-testing | 150 (68.5) |
STIs testing in the past year | Â |
 No | 145 (52.3) |
 Yes |  |
  Gonorrhea | 23 (8.3) |
  Chlamydia | 15 (5.4) |
  Syphilis | 124 (44.8) |
  HPV | 33 (11.9) |
  HSV2 | 8 (2.9) |
PrEP use | Â |
 Yes | 24 (8.7) |
 No | 252 (91.3) |
PEP use | Â |
 Yes | 29 (10.9) |
 No | 238 (89.1) |
Living with HIV | 20 (9.1) |